Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia

This study is ongoing, but not recruiting participants.

Study NCT00004878 Information provided by National Cancer Institute (NCI)

First Received: March 7, 2000 Last Updated: February 6, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Graft Versus Host Disease
Leukemia

Additional conditions recognized in this trial

Graft vs Host Disease
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myeloid

More general conditions related to this trial

Bone Marrow Diseases
Hematologic Diseases
Immune System Diseases
Myeloproliferative Disorders
Neoplasms
Neoplasms by Histologic Type

Interventions listed in this trial

therapeutic allogeneic lymphocytes
cytarabine
fludarabine phosphate
idarubicin
methotrexate
tacrolimus

Additional drug interventions recognized in this trial

Fludarabine
Fludarabine monophosphate
Vidarabine

Sponsors listed in this trial

Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Back to top of Main Content